Michael Johnson, CEO, Rhinomed Ltd 00:00:00

Share On Facebook Share On Twitter

Rhinomed (ASX:RNO) is a leader in wearable nasal and respiratory technology. CEO & MD Michael Johnson discusses the potential for Rhinoswab and Rhinoswab Junior Covid-19 nasal swabs to revolutionise the Covid-19 testing process and user experience.

Recent Videos